->

Tag: lymphoma follicular

Bogga Hore / Sanad La Aasaasay

, , , , , ,

Tisagenlecleucel waxa u ansixisay FDA dib u soo noqoshada ama limfoma follicular refractory

Juun 2022: Laba ama in ka badan oo daawaynta habaysan ka dib, FDA waxay siisay tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) oo dadajisay oggolaanshaha bukaanada qaangaarka ah ee dib u soo noqday ama dib u soo noqday follicular lymphoma (FL).T.

, , , , , , ,

FDA waxay siisay axicabtagene ciloleucel oggolaansho degdeg ah oo loogu talagalay dib -u -noqoshada ama lymfoma follicular refractory.

Agoosto 2021: FDA waxay siisay axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) oggolaanshaha degdega ah ee bukaanada qaangaarka ah ee soo noqnoqda ama follicular lymphoma (FL) ka dib laba ama in ka badan oo daawaynta habaysan. hees

Bilow sheekada
Waxaan nahay Online! Nala hadal!
Sawir koodka
Hello,

Ku soo dhawoow CancerFax!

CancerFax waa madal horudhac ah oo u heellan in lagu xidho shakhsiyaadka wajahaya kansarka heerka sare ee daawaynta unugyada sida CAR T-Cell therapy, daawaynta TIL, iyo tijaabooyinka caafimaad ee adduunka oo dhan.

Nala soo socodsii waxaan kuu qaban karno.

1) Daaweynta kansarka ee dibadda?
2) CAR T-Cell therapy
3) Tallaalka kansarka
4) La-talinta fiidiyowga ee khadka tooska ah
5) daawaynta Proton